Tag: Health Care

Displaying 681 - 700 of 826 results.

The dental association with a membership of more than 1800 dentists practicing in Puerto Rico agreed not to encourage its members to enter into agreements that set or fixed the fees charged or terms and conditions under which dentists would deal with health insurance plans or other...
The Colegio de Cirujanos Dentistas de Puerto Rico ("Colegio"), an association of approximately 1800 dentists licensed to practice dentistry in Puerto Rico, has agreed to settle Federal Trade Commission charges that it restrained competition among dentists in Puerto Rico by fixing the terms under...
A consent order settled allegations in an administrative complaint that charged that Hoechst agreed to pay Andrx Corporation millions of dollars not to market and distribute a generic version of Hoechst’s branded Cardizem CD, a once-a-day diltiazem drug product used in the treatment...
Abbott and Geneva Pharmaceuticals settled charges that the two firms entered into an illegal agreement to stop the marketing and development of a competing generic drug. According to the complaint, Abbott, manufacturer of Hytrin – the brand name for terazosin HCL, a prescription drug...
The Wisconsin Chiropractic Association and its executive director, Russell A. Leonard, settled charges that they conspired to fix the prices for chiropractic goods and services and to boycott third party payers in an attempt to obtain higher reimbursement rates for services and...
The Wisconsin Chiropractic Association (WCA) and its executive director, Russell A. Leonard, have agreed to settle Federal Trade Commission allegations that they orchestrated a conspiracy among WCA members to increase prices for chiropractic services and to boycott third-party payers to obtain...
Federal Trade Commission Chairman Robert Pitofsky today told the House Judiciary Committee that a proposed antitrust exemption to allow physicians and other health care professionals to engage in collective bargaining with health plans would be bad medicine for consumers. "Without antitrust...
The Federal Trade Commission today announced the following action. Petitions to reopen and modify or set aside orders: The FTC has approved a petition from the following entity seeking changes in, or termination of, an FTC order.
A plan to establish a network of independent community pharmacies and pharmacists, that would contract with managed care organizations and physician groups to provide both drug distribution and disease management services, appears to present an innovative approach with the potential for...
Final order settles charges that Sorin Biomedica S.p.A.'s acquisition of COBE Cardiovascular, Inc. would eliminate competition in the United states market for research, development, manufacture and sale of heart-lung machines. The order permits the acquisition and requires the...
The Federal Trade Commission announces the following actions.  
Consent order, resolving antitrust concerns relating to Zeneca's merger with Astra AB requires the divestiture of all assets relating to levobupivacaine, a long-acting local anesthetic. The assets were sold to Chiroscience Group plc, the developer of levobupivacaine.
Physicians practicing in the North and South Lake Tahoe areas settled charges that they conspired to fix the prices and terms for professional services. The consent order prohibits the IPA from engaging in collective negotiations to fix prices; refusing to deal with third party...
North Lake Tahoe Medical Group, Inc. (Tahoe IPA) -- a for-profit corporation that comprises at least 70 percent of all physicians practicing in the North and South Lake Tahoe areas -- has agreed to settle Federal Trade Commission charges that it restrained competition among physicians by fixing or...
Consent agreements given final approval: Following a public comment period, the Commission has made final consent agreements with the following entities. The Commission action makes the consent orders binding on the respondents.
Medtronic agreed to divest Avecor Cardiovascular, Inc.'s non-occlusive arterial pump assets to settle antitrust concerns that the acquisition would lessen competition for the research, development, manufacture and sale of the pumps in the United States. The order requires Medtronic...
Consent agreements given final approval: Following a public comment period, the Commission has made final consent agreements with the following entities. The Commission action makes the consent orders binding on the respondents.
Complaint filed in the U.S. District Court for the District of Columbia charged Mylan with restraint of trade, monopolization and conspiracy to monopolize the market for two generic drugs used to treat anxiety, lorazepam and clorazepate, through exclusive dealing arrangements.  The...
Mylan Laboratories, Inc., the nation’s second largest generic drug manufacturer, and three other companies, were charged today by the Federal Trade Commission with restraint of trade, monopolization and conspiracy to monopolize the markets for two widely-prescribed anti-anxiety drugs, lorazepam...

Pages